Cholestasis Markers – Lab Values for Bile Flow
Cholestasis markers are laboratory values that indicate impaired bile flow. They help doctors detect liver diseases and bile duct disorders at an early stage.
Wissenswertes über "Cholestasis Markers"
Cholestasis markers are laboratory values that indicate impaired bile flow. They help doctors detect liver diseases and bile duct disorders at an early stage.
What Are Cholestasis Markers?
Cholestasis markers are specific blood laboratory parameters that indicate cholestasis – a condition in which bile flow is impaired or obstructed. When bile cannot be properly transported away from the liver, substances such as bile acids, bilirubin, and enzymes accumulate in the bloodstream. These markers are a key tool in the diagnosis of liver and biliary tract diseases.
The Most Important Cholestasis Markers
The following laboratory values are commonly used as cholestasis markers in clinical practice:
- Alkaline Phosphatase (ALP): An enzyme that is released in increased amounts during bile flow obstruction. Elevated levels indicate intrahepatic or extrahepatic cholestasis.
- Gamma-Glutamyl Transferase (GGT): A particularly sensitive marker for liver disease and bile duct disorders. GGT levels rise even with minor disturbances in bile flow.
- Bilirubin (direct/conjugated bilirubin): Direct bilirubin is processed in the liver and excreted via bile. In cholestasis, it accumulates in the blood and can cause jaundice (icterus).
- 5-Nucleotidase (5-NT): A liver-specific enzyme that is elevated in biliary tract disease and helps differentiate the cause of elevated ALP levels.
- Leucine Aminopeptidase (LAP): Also released during bile stasis and used as a supplementary diagnostic marker.
- Serum Bile Acids: Directly measurable bile acids are a highly specific marker for impaired bile secretion, particularly in pregnancy (intrahepatic cholestasis of pregnancy).
Causes of Cholestasis
The causes of cholestasis are divided into two main groups:
Intrahepatic Cholestasis
The obstruction originates within the liver itself. Common causes include:
- Viral hepatitis (Hepatitis A, B, C)
- Alcoholic liver disease
- Primary biliary cholangitis (PBC)
- Primary sclerosing cholangitis (PSC)
- Drug-induced liver injury
- Intrahepatic cholestasis of pregnancy
Extrahepatic Cholestasis
The obstruction is located outside the liver, in the bile ducts. Common causes include:
- Gallstones in the common bile duct (choledocholithiasis)
- Tumors of the pancreas or bile ducts
- Biliary strictures (narrowings)
- Inflammation of the bile ducts (cholangitis)
Symptoms of Cholestasis
Cholestasis can manifest through various symptoms:
- Yellowing of the skin and eyes (jaundice/icterus)
- Itching (pruritus) caused by bile acid deposits in the skin
- Pale, clay-colored stools (acholic stools)
- Dark urine due to elevated bilirubin levels
- Fatigue and general malaise
- Upper abdominal pain (particularly with gallstones)
Diagnosis and Interpretation of Markers
Elevated cholestasis markers are identified through a blood test (liver function test). For further evaluation, physicians use the following investigations:
- Ultrasound (sonography): The first-line imaging method for assessing the liver and bile ducts.
- MRCP (Magnetic Resonance Cholangiopancreatography): Non-invasive visualization of the bile ducts using MRI.
- ERCP (Endoscopic Retrograde Cholangiopancreatography): An invasive procedure used for both diagnosis and treatment of bile duct disorders.
- Liver biopsy: A tissue sample for histological examination in cases with unclear findings.
Cholestasis markers are always interpreted in conjunction with other liver values such as transaminases (AST, ALT), clinical symptoms, and imaging results.
Treatment
Treatment of cholestasis depends on the underlying cause:
- Medical therapy: For primary biliary cholangitis, ursodeoxycholic acid (UDCA) is used; itching may be treated with cholestyramine or rifampicin.
- Interventional therapy: Removal of gallstones via ERCP, placement of biliary stents for strictures.
- Surgical therapy: Indicated for tumors or complex biliary tract problems.
- Treatment of the underlying condition: For example, antiviral therapy for viral hepatitis or discontinuation of causative medications.
References
- European Association for the Study of the Liver (EASL) - Clinical Practice Guidelines on Intrahepatic Cholestasis of Pregnancy. Journal of Hepatology, 2023.
- Beuers, U. et al. - Cholestatic Liver Diseases: An Algorithmic Approach. New England Journal of Medicine, 2023.
- Feldman, M. et al. - Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 11th ed. Elsevier, 2021.
Best-selling products
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryExtrauterine
Nutrient Biosynthesis Pathway
Growth Hormone Analysis
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Cholestasis Markers + Cholestasis Parameters + Cholestatic Markers